| human | Q5 |
| P108 | employer | Université de Versailles Saint-Quentin-en-Yvelines | Q186638 |
| hôpital Foch | Q3145155 | ||
| P735 | given name | Emmanuel | Q18001873 |
| Emmanuel | Q18001873 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q96226501 | ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice |
| Q42518849 | Acid-induced modulation of airway basal tone and contractility: role of acid-sensing ion channels (ASICs) and TRPV1 receptor |
| Q35908093 | Airway response to acute mechanical stress in a human bronchial model of stretch |
| Q51760335 | Daily allergic multimorbidity in rhinitis using mobile technology: a novel concept of the MASK study. |
| Q35642129 | Effectiveness of a load-imposing device for cyclic stretching of isolated human bronchi: a validation study |
| Q34221590 | Expression and function of human hemokinin-1 in human and guinea pig airways |
| Q42691183 | Expression and proliferative effect of hemokinin-1 in human B-cells |
| Q92818550 | Google Trends and pollen concentrations in allergy and airway diseases in France |
| Q33823753 | Human lung and monocyte-derived macrophages differ with regard to the effects of β2-adrenoceptor agonists on cytokine release |
| Q33722804 | In smokers, Sonic hedgehog modulates pulmonary endothelial function through vascular endothelial growth factor. |
| Q42781687 | Intranasal delivery of systemic drugs: a new route for opioid drugs |
| Q37998744 | Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. |
| Q39197821 | Long-term treatment strategy in chronic obstructive pulmonary disease: how to change the course of the disease |
| Q39109837 | Metabolomics in the Diagnosis and Pharmacotherapy of Lung Diseases |
| Q99638689 | Personalized Medicine for allergy treatment: allergen immunotherapy still a unique and unmatched model |
| Q30239093 | Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study |
| Q34997388 | Roflumilast inhibits lipopolysaccharide-induced tumor necrosis factor-α and chemokine production by human lung parenchyma |
| Q38285159 | Taste receptors in asthma |
| Q40041662 | The ARIA score of allergic rhinitis using mobile technology correlates with quality-of-life: The MASK study. |
| Q34248500 | The expression and relaxant effect of bitter taste receptors in human bronchi. |
| Q42368656 | The impact of low-frequency, low-force cyclic stretching of human bronchi on airway responsiveness |
| Q35865433 | The long-acting β2 -adrenoceptor agonist olodaterol attenuates pulmonary inflammation. |
| Q38566367 | The pharmacology of bitter taste receptors and their role in human airways |
| Q34434700 | Wnt/β-catenin signaling modulates human airway sensitization induced by β2-adrenoceptor stimulation |
Search more.